Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 11, 2005, Pages 965-969

  Robbins, K Thomas ^a   Doweck, Ilana ^b   Samant, Sandeep ^c   Vieira, Francisco ^c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CARMEL MEDICAL CENTER   (Israel)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; NECK DISSECTION; PROSPECTIVE STUDY; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; LYMPHATIC METASTASIS; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 28144438405     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.131.11.965     Document Type: Article

References (18)

1. Robbins KT. The evolving role of combined modality therapy in the head and neck cancer. Arch Otolaryngol Head Neck Surg. 2000;126:265-269.
2. Robbins KT, Wong FSH, Kumar P, et al. Efficacy of targeted chemotheradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125:670-675.
3. Clayman GL, Johnson CJ, Morrison W, Ginsberg L, Lippman SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg. 2001;127:135-139.
4. Wang SJ, Wang MB, Yip H, Calcaterra TC. Combined radiotherapy with planned neck dissection for small head and neck cancer with advanced cervical metastases. Laryngoscope. 2000;110:1794-1797.
5. Brizel DM, Prosnitz RG, Hunter S, et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:1418-1423.
6. Velazquez RA, McGuff HS, Sycamore D, Miller FR. The role of computed tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy. Arch Otolaryngol Head Neck Surg. 2004;130:74-77.
7. Roy S, Tibesar RJ, Daly K, et al. Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy. Head Neck. 2002;24:474-481.
8. Rogers JW, Greven KM, McGuirt WF, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys. 2004;58:694-697.
9. Ojiri H, Mendenhall WM, Stringer SP, Hohnson PL, Mancuso AA. Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:420-428.
10. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complication from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg. 1999;125:401-405.
11. Kuntz AL, Weymuller EA Jr. Impact of neck dissection on quality of life. Laryngoscope. 1999;109:1334-1338.
12. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405-409.
13. Stenson KM, Haraf DJ, Pelzer H, et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg. 2000;126:950-956.
14. Doweck I, Robbins KT, Mendenhall WM, et al. Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy? Head Neck. 2003;25:960-967.
15. Newkirk KA, Cullen KJ, Harter KW, Picken CA, Sessions RB, Davidson BJ. Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck. 2001;23:73-79.
16. Narayan K, Crane CH, Kleid S, Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck dissection treated with definitive radiotherapy: for some or for all? Head Neck. 1999;21:606-613.
17. Robbins KT, Doweck I, Samant S, Vieira F, Kumar P. Factors predictive of local disease control after intra-arterial concomitant chemoradiation (RADPLAT). Laryngoscope. 2004;114:411-417.
18. Proctor E, Robbins KT, Vieira F, Hanchett C, Sommes G. Postoperative complications after chemoradiation for advanced head and neck cancer. Head Neck. 2004;26:272-277.